Skip to main content

cancer immunotherapy

New prostate cancer treatment concept

Aug. 22, 2019—Combining immunotherapy and radiation therapy may be a powerful treatment approach for castration-resistant prostate cancer.

Read more


Encephalitis identified as rare toxicity of immunotherapy treatment

Jul. 22, 2019—Researchers are chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies.

Read more


Nanoparticle targets tumor-infiltrating immune cells, flips switch telling them to fight

Jan. 21, 2019—A team of Vanderbilt University bioengineers announced a major breakthrough: designing a nanoscale particle that flips on cells' defenses to fight cancer.

Read more


Cancer immunotherapy drugs linked with more serious heart effects

Mar. 12, 2018—Vanderbilt University Medical Center investigators have identified a growing number of serious and sometimes fatal cases of heart problems among cancer patients treated with some forms of immunotherapy.

Read more


VIEW MORE EVENTS >